Cargando…

Cost-effectiveness of routine adolescent vaccination with an M72/AS01(E)-like tuberculosis vaccine in South Africa and India

The M72/AS01(E) tuberculosis vaccine showed 50% (95%CI: 2–74%) efficacy in a phase 2B trial in preventing active pulmonary tuberculosis disease, but potential cost-effectiveness of adolescent immunisation is unknown. We estimated the impact and cost-effectiveness of six scenarios of routine adolesce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, Rebecca C., Quaife, Matthew, Weerasuriya, Chathika, Gomez, Gabriela B., Sumner, Tom, Bozzani, Fiammetta, White, Richard G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807591/ https://www.ncbi.nlm.nih.gov/pubmed/35105879 http://dx.doi.org/10.1038/s41467-022-28234-7

Ejemplares similares

New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01(E) and BCG-revaccination
por: Clark, Rebecca A, et al.
Publicado: (2023)

New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01(E) and BCG-revaccination
por: Clark, Rebecca A., et al.
Publicado: (2023)

The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
por: Weerasuriya, Chathika K, et al.
Publicado: (2021)

Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
por: Weerasuriya, Chathika K., et al.
Publicado: (2022)

Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis
por: Weerasuriya, Chathika Krishan, et al.
Publicado: (2021)

Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis
por: Jayawardana, Sahan, et al.
Publicado: (2022)

Informing Balanced Investment in Services and Health Systems: A Case Study of Priority Setting for Tuberculosis Interventions in South Africa
por: Bozzani, Fiammetta M., et al.
Publicado: (2020)

The potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study
por: Clark, Rebecca A, et al.
Publicado: (2023)

Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination
por: Weerasuriya, Chathika Krishan, et al.
Publicado: (2022)

The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
por: Portnoy, Allison, et al.
Publicado: (2023)

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
por: Portnoy, Allison, et al.
Publicado: (2023)

Estimating the Impact of Tuberculosis Case Detection in Constrained Health Systems: An Example of Case-Finding in South Africa
por: Sumner, Thomas, et al.
Publicado: (2019)

Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa
por: Hippner, Piotr, et al.
Publicado: (2019)

Empirical estimation of resource constraints for use in model-based economic evaluation: an example of TB services in South Africa
por: Bozzani, Fiammetta M., et al.
Publicado: (2018)

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
por: Clark, Rebecca A, et al.
Publicado: (2023)

Immunogenicity and Safety of the M72/AS01(E) Candidate Vaccine Against Tuberculosis: A Meta-Analysis
por: Ji, Zhenhua, et al.
Publicado: (2019)

Is neglect of self-clearance biassing TB vaccine impact estimates?
por: Scarponi, Danny, et al.
Publicado: (2023)

Using system dynamics modelling to estimate the costs of relaxing health system constraints: a case study of tuberculosis prevention and control interventions in South Africa
por: Bozzani, Fiammetta M, et al.
Publicado: (2021)

Is neglect of self-clearance biasing TB vaccine impact estimates?
por: Scarponi, Danny, et al.
Publicado: (2023)

Access to Routine Immunization: A Comparative Analysis of Supply-Side Disparities between Northern and Southern Nigeria
por: Eboreime, Ejemai, et al.
Publicado: (2015)

The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study
por: Portnoy, Allison, et al.
Publicado: (2023)

Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines
por: Pelzer, Puck T., et al.
Publicado: (2022)

A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults
por: Kumarasamy, Nagalingeswaran, et al.
Publicado: (2016)

Phase 2b placebo-controlled trial of M72/AS01(E) candidate vaccine to prevent active tuberculosis in adults
por: Van Der Meeren, Olivier, et al.
Publicado: (2018)

The Systematic Review and Meta-Analysis on the Immunogenicity and Safety of the Tuberculosis Subunit Vaccines M72/AS01(E) and MVA85A
por: Ullah, Inayat, et al.
Publicado: (2020)

Complexity and evidence in health sector decision-making: lessons from tuberculosis infection prevention in South Africa
por: Perera, Shehani, et al.
Publicado: (2022)

Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study
por: Verguet, Stéphane, et al.
Publicado: (2017)

A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults
por: Montoya, Jaime, et al.
Publicado: (2013)

Safety and immunogenicity of candidate vaccine M72/AS01(E) in adolescents in a TB endemic setting
por: Penn-Nicholson, Adam, et al.
Publicado: (2015)

Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette–Guérin-Vaccinated Adults
por: van den Berg, Robert A., et al.
Publicado: (2018)

120. A Randomized Double-blind Trial Assessing the Efficacy of M72/AS01(E) Vaccine Against Pulmonary Tuberculosis Disease in Adults With Latent Mycobacterium tuberculosis Infection
por: Meeren, Olivier Van Der, et al.
Publicado: (2018)

A bibliometric analysis of systematic reviews on vaccines and immunisation
por: Fernandes, Silke, et al.
Publicado: (2018)

Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review
por: Bozzani, Fiammetta M., et al.
Publicado: (2022)

High Sequence Variability of the ppE18 Gene of Clinical Mycobacterium tuberculosis Complex Strains Potentially Impacts Effectivity of Vaccine Candidate M72/AS01E
por: Homolka, Susanne, et al.
Publicado: (2016)

Should India be considering deployment of the first malaria vaccine RTS, S/AS01?
por: Rahi, Manju, et al.
Publicado: (2022)

Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable?
por: Griffiths, Ulla Kou, et al.
Publicado: (2016)

Modelling the effect of infection prevention and control measures on rate of Mycobacterium tuberculosis transmission to clinic attendees in primary health clinics in South Africa
por: McCreesh, Nicky, et al.
Publicado: (2021)

A review of the safety of vaccines used in routine immunization in Africa
por: Yamoah, Peter, et al.
Publicado: (2020)

A novel formulation of Mtb72F DNA vaccine for immunization against tuberculosis
por: Dalirfardouei, Razieh, et al.
Publicado: (2020)

Building resource constraints and feasibility considerations in mathematical models for infectious disease: A systematic literature review
por: Bozzani, Fiammetta M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6c6dglknoro3lu70oadijjvmhk